CDC Press Conference on Recommendations for Use of Vaccine Against Novel Influenza A (H1N1)

Friday, September 18, 2009 General News J E 4

WHAT: CDC will host a press conference to discuss an update on the proceedings of the Advisory Committee on Immunization Practices and its recommendations for the use of a vaccine against novel influenza A (H1N1).

WHO: Anne Schuchat, M.D., Director, National Center for Immunization and Respiratory Diseases, CDC

WHEN: Wednesday, July 29, 2009 at 3:30 p.m. ET

WHERE: Centers for Disease Control and Prevention

1600 Clifton Road NE

Atlanta, GA 30329

Tom Harkin Global Communications Center (Building 19), Press Room

For directions to CDC, please visit Parking is available in the Building 19 parking deck located on CDC Parkway. Media should arrive at the CDC by 3:00 p.m. Media must present photo ID for access.

Media who cannot attend in person can listen and ask questions by toll-free conference line. The briefing will begin promptly; media should dial in a few minutes before the start of the conference.


*Please dial in 10 to 15 minutes before the start of the press conference. We will begin promptly at 3:30 p.m. ET. Media: 888-795-0855

Listen Only: 800-619-8524

INTERNATIONAL: 1-773-756-4707


Important Instructions: If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.


Call Crawford Communications Bookings at 1-800-243-1995 to make arrangements for broadcast feed.


This press briefing media will also be available via listen-only audio Web site at We strongly encourage non-media participants to use the webcast.


A transcript of this media availability will be available following the briefing at the CDC Web site at

CONTACT: CDC Media Relations, +1-404-639-3286

/PRNewswire-USNewswire -- July 28/

SOURCE Centers for Disease Control and Prevention


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
DURECT to Present at the BMO Capital Markets Healt...
Zix Corporation Reports Another Record-High Revenu...